Search Results - "Leath, C."

Refine Results
  1. 1
  2. 2
  3. 3

    Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey by Dholakia, J., Kim, J., Liang, M.I., Arend, R.C., Bevis, K.S., Straughn, J.M., Leath, C.A., Huh, W.K., Smith, H.J.

    Published in Gynecologic oncology reports (01-11-2021)
    “…•Even prior to COVID-19, gynecologic oncology patients were interested in telemedicine as a component of their care.•The majority of patients have home…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter by Zhu, Z B, Makhija, S K, Lu, B, Wang, M, Kaliberova, L, Liu, B, Rivera, A A, Nettelbeck, D M, Mahasreshti, P J, Leath, 3rd, C A, Yamamoto, M, Yamaoto, M, Alvarez, R D, Curiel, D T

    Published in Gene therapy (01-04-2004)
    “…Adenoviral vectors are considered to be good gene delivery vectors for cancer gene therapy due to their wide host tissue range and cell cycle-independent…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer by Havrilesky, Laura J, Leath, Charles A, Huh, Warner, Calingaert, Brian, Bentley, Rex C, Soper, John T, Alvarez Secord, Angeles

    Published in Gynecologic oncology (01-05-2004)
    “…Objective. We wished to evaluate survival and adverse outcomes of patients with stage IB2 cervical cancer treated primarily with radical hysterectomy and…”
    Get full text
    Journal Article